MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Clinical features"

  • 2022 International Congress

    All that emerge is not Lupus

    M. Spitz, S. de Souza, I. Sodré, B. Panichelli (Rio de Janeiro, Brazil)

    Objective: The aim of this article is to report a rare case of Huntington's disease (HD) in a patient with chorea and previous diagnosis of…
  • 2022 International Congress

    Reversible chorea due to bilateral basal ganglia lesion in diabetic uremic patient

    B. Tserensodnom (Ulaanbaatar, Mongolia)

    Objective: To report diabetic patient with chronic renal failure who developed sudden chorea movements associated with reversible bilateral basal ganglia lesion. Background: Acute movement disorder…
  • 2022 International Congress

    Juvenile Huntington’s Disease in Tunisia: Clinical Diversity and Literature review

    H. Nehdi, E. Chebbi, F. Nabli, Z. Saied, S. Ben Sassi, R. Amouri (Tunis, Tunisia)

    Objective: We conducted the first JHD clinical and molecular features in Tunisia and North Africa, contributing to better understanding the diverse manifestation of the disease…
  • 2022 International Congress

    Cognitive profiling in a cohort of Huntington’s disease (HD) patients

    M. Garon, F. Pistonesi, L. Weis, V. Cianci, T. Gandolfi, E. Fiorenzato, C. Tedesco, M. Campagnolo, M. Carecchio, A. Antonini, R. Biundo (Padua, Italy)

    Objective: To define neuropsychological profile of HD patients adopting Parkinson’s disease Level II criteria for cognitive diagnosis[1]. Background: HD is a rare autosomal dominant genetic…
  • 2022 International Congress

    Mimics or multiplicity: two patients with a PSP phenotype and underlying genetic neurodegenerative disorders.

    S. Lyons, R. Walsh, T. Lynch, S. O'Dowd (Dublin, Ireland)

    Objective: To describe a two cases of patients presenting with a PSP phenotype and genetic findings consisted with Huntington’s disease (HD) in one case and…
  • 2022 International Congress

    Nocturnal attacks of abnormal sleep behaviors and abnormal movements induced by insulin: A case report

    S. El-Jaafary (Cairo, Egypt)

    Objective: To report a case of abnormal sleep behavior associated with hypoglycemia induced by insulin. Background: Hypoglycemia is a serious condition that can be manifested…
  • 2022 International Congress

    Speech markers of Presymptomatic and Prodromal Huntington’s disease

    A. Vogel, C. Chan, G. Stuart, P. Maruff, Y. Lie, J. Stout (Melbourne, Australia)

    Objective: To investigate the sensitivity of digital speech measures for detecting subtle cognitive-linguistic and fine motor features in people carrying the expanded HD gene, with…
  • 2022 International Congress

    Analysis of Depression and Suicidality Throughout the Course of Huntington Disease Using the Enroll-HD Registry

    S. Reshef, E. Furr Stimming, V. Sung, R. Willock, R. Ribalov, S. Brighton, S. Leo (Parsippany, USA)

    Objective: To describe the frequency of depression and suicidality among patients with Huntington disease (HD) stratified by HD stage and chorea severity. Background: High rates…
  • 2022 International Congress

    Anosognosia in HD: Comparison of Self-report and Caregiver Ratings with Objective Performance Measures

    SB. Hughes, A. Smirnova, A. Hall, C. Snell, B. Wright, PE. Gilbert, J. Corey-Bloom (San Diego, USA)

    Objective: Objective: To compare patient and caregiver report of cognitive, motoric, and psychiatric symptoms versus objective performance measures in patients with Huntington’s disease (HD). Background:…
  • 2022 International Congress

    Olfactory dysfunction in patients with Huntington disease

    J. Patino, H. Coco, S. Zadegan, S. Chandra, N. Karagas, N. Rocha, K. Anderson, A. Teixeira, E. Furr Stimming (Houston, USA)

    Objective: To investigate olfactory dysfunction (OD) in individuals with Huntington disease (HD) and its relation to disease severity. Background: HD is a hereditary neurodegenerative disease…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 20
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An atypical and interesting feature of Parkinson´s disease
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley